Coloplast A/S EBIT

As of the most recent data (June 2026), CBHD.DE shows a EBIT of $6B. That compares with $7.4B in the prior-year period — down 19.1% year over year. That is below the Healthcare sector average of $22B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CBHD.DE's EBIT is now $6B (was $7.4B) — a 19.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Coloplast A/S is outperforming or lagging.

The Healthcare sector average EBIT is about $22B. Coloplast A/S is at $6B, which is lower that average. That is roughly 73.1% below the sector mean. Use the comparison chart on this page to see how CBHD.DE stacks up against individual peers as well.

Tracking CBHD.DE's ebit over time shows whether Coloplast A/S is scaling, shrinking, or reshaping that part of the business. The current reading is $6B That compares with $7.4B in the prior-year period — down 19.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Coloplast A/S's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $6B) with ownership activity and broader fundamentals.